Global Escitalopram Market is expected to grow at a CAGR of 2.9% from 2020 to 2027

Escitalopram is frequently prescribed by psychiatrists throughout the globe for the treatment of mental illness such as major depressive disorders, generalized anxiety disorders, post-traumatic stress disorders, etc. Least side effect profile, high tolerability, and minimum damage caused to the hepatic cytochrome enzymes have made a highly popular drug in treating mental disorders and are recorded […]